Results 211 to 220 of about 368,839 (349)
Morphological analysis and functional connectivity of the insular in patients with dysphagia after cerebral infarction based on resting-state fMRI. [PDF]
Guo M+9 more
europepmc +1 more source
ESSAY UPON THE CONNEXION BETWEEN THE CEREBELLUM AND THE CEREBRO-SPINAL AXIS [PDF]
Holmes Coote
openalex +1 more source
The gamma-aminobutyric acid system in rabbit cerebellum. [PDF]
Kengo Kuriyama+3 more
openalex +1 more source
Objectives Prospective studies demonstrated that essential tremor is a risk factor for Parkinson's disease. Identifying clinical markers for conversion from essential tremor to essential tremor‐Parkinson's disease would be of considerable value. Rest tremor can be present in advanced essential tremor and may be a harbinger of conversion. We examined (1)
Elan D. Louis+3 more
wiley +1 more source
Compensatory cerebellar activation during fluid intelligence processing following mild traumatic brain injury. [PDF]
Leibovici A+18 more
europepmc +1 more source
Objectives To examine volumetric magnetic resonance imaging (vMRI) in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD), compared to multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and healthy controls (HC). Methods Standardized vMRI in MOGAD were compared to age, sex, and disease duration matched MS (5:1),
Amy Kunchok+10 more
wiley +1 more source
Advances in Cerebellar TMS Therapy: An Updated Systematic Review on Multi-Session Interventions. [PDF]
Ciricugno A+5 more
europepmc +1 more source
Objective The objective of this study was to investigate the relationships among subthalamic nucleus (STN) activity, gait initiation (GI), and freezing of gait (FOG) in patients with Parkinson's disease (PD). Methods We recorded GI and STN local field potentials (LFPs) via externalized cables in 38 patients with PD (35 reporting FOG in daily life ...
Antoine Collomb‐Clerc+12 more
wiley +1 more source
Functional development of the human cerebellum from birth to age five. [PDF]
Lyu W+6 more
europepmc +1 more source
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam+29 more
wiley +1 more source